Serum Markers IPS, TPA and CA 15-3 as monitors of chemotherapy in patients with metastatic breast cancer

Journal of Tumor Marker Oncology

Volumn 15, Issue 3, 2000, Pages 177-186

  Lindman, H ^a,b,c   Jansson, T ^a,b,c   Arnberg, H ^a,b,c   Bergh, J ^a,b,c   Einarsson, R ^a,b,c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c IDL Biotech   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0008075561     PISSN: 08863849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Robertson JFR: Blood tumor markers in breast cancer. Tumor Marker Update 1998; 10:31-37.
2. Lamerz R: Circulating tumor markers in breast cancer. Tumor Marker Update 1995; 7: 95-100.
3. Murray A, Clinton O, Earl H, Price M, Moore A: Assessment of five serum marker assays in patients with advanced breast cancer treated with medroxyprogesterone acetate. Eur J Cancer 1995; 31 A: 1605-1610.
4. Lamerz R et al: Role of blood markers in the detection of métastases from primary breast cancer. Oncology 1991.
5. Staab HJ: Biologie und Chemie des CEA. In Tumormarkersystem CEATPA (eds Lüthgens M, Schlegel G) Tumor Diagnostik Verlag, Leonberg, 1987, pp 30-46.
6. Björklund B, Björklund V: Biochemische und morphologische Grundlagen von TPA: Fortschritte in Richtung auf einem allgemeinen Marker für aktive Tumoren durch monoklonale Kartierung. In: Tumormarkersystem CEA-TPA (eds Lüthgens M, Schlegel G) Tumor Diagnostik Verlag, Leonberg, 1987, pp 14-27.
7. Weber K, Osborn M, Moll R, Wiklund B, Lüning B: Tissue polypeptide antigen (TPA) is related to the nonepidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker. EMBO J 1984; 3: 27072714.
8. ASCO Tumor Marker Panel: Clinical practice guidelines for the use of tumor markers in breast cancer and colorectal cancer. J Clin Oncol 1996; 10:2843-2877.
9. van Dalen A, Heering KJ, Barak V, Peretz T, Cremaschi A, Geroni P, Gion M, Saracchini S, Molina R, Namer M, Stieber P, Sturgeon C, Leonard RCF, Einarsson R: Treatment response in metastatic breast cancer. A multicenter study comparing UICC criteria and tumor marker changes. The Breast 1996; 5: 82-88.
10. Schuurman JJ, Bong SB, Einarsson R: Determionation of serum tumor markers TPS and CA 15-3 during monitoring of treatment in metastatic breast cancer patients. Anticancer Res 1996; 16: 2169-2172.
11. Barak V, Nisman B, Roisman I, Hubert A, Farbstein H, Baider L, Kaplan A, Halperin T, Stephanos S, Peretz T: TPS in assessing response to therapy and prognosis of breast cancer patients treated with interferons. J Tumor Marker Oncol 1997; 12:17-25.
12. Rydlander L, Ziegler E, Bergman T, Schöberl E, Steiner G, Bergman A-C, Zetterberg A, Marberger M, Björklund P, Skern T, Einarsson R, Jörnvall H: Molecular characterization of tissuepolypeptide-specific-antigen epitope and its relationship to human cytokeratin 18. Eur J Biochem 1996; 241:309-314.
13. Björklund B, Einarsson R: TPS (Tissue Polypeptide Specific Antigen) in onclogic practice: A review with reference to 3000 cases of breast cancer. TumorDiagn u. Ther 1996; 17: 67-73.
14. Einarsson R, Barak V: TPS a cytokeratin serum tumor marker for effective therapy control of cancer patients. J Clin Ligand Assay (In press, 2000).
15. Tondini C, Hayes DF, Gelman R, Henderson TC, Kufe DW: Comparison of CA 15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. Cancer Res 1988; 48: 4107-4112.
16. Nicolini A, Colombini C, Luciani L, Carpi A, Giuliani L: Evaluation of serum CA 15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. Br J Cancer 1991; 64: 154-158.
17. van Dalen A, Barak V, Cremaschi A, Gion M, Molina R, Namer M, Stieber P, Sturgeon C, Einarsson R: The prognostic significance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease. Int J Biol Markers 1998; 13: 10-15.
18. Giai M, Roagana R, Ponzone R, Biglia N, Sgro L, Perona M, Sismondi P: TPS and CA 15-3 serum values as a guide for treating and monitoring breast cancer patients. Anticancer Res 1996; 16:875-882.
19. Dnistrian AM, Schwartz MK, Greenberg EJ, Smith CA, Schwartz DC: Evaluation of CAM26, CAM29, CA 15-3 and CEA as circulating tumor markers in breast cancer patients. Tumor Biol 1991; 12: 1282-1290.
20. Molina R, Zanon G, Filella X, Moreno F, Jo J, Daniels M, Latre ML, Gimenez N, Pahisa J, Velasco M, Ballesta AM: Use of serial carcinoembryonic antigen and CA 15-3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat 1995;36:41-48.